Trial
NCT01524068
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pittsburgh
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis
Intervention
Standard Steroid Treatment
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-05